Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

: CureVac's COVID vaccine candidate 47% effective, stock tanks

Market Watch - 16 Jun 2021 23:47
Shares of Curevac NV plunged more than 50% in the extended session Wednesday after the pharma company said its trial COVID-19 vaccine showed an efficacy of 47% against the illness.
Full Article at Market Watch

More Business News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard